Marine Drugs (Nov 2022)

Anti-Biofilm Activity of a Hyaluronan-like Exopolysaccharide from the Marine <i>Vibrio</i> MO245 against Pathogenic Bacteria

  • Marie Champion,
  • Emilie Portier,
  • Karine Vallée-Réhel,
  • Isabelle Linossier,
  • Eric Balnois,
  • Guillaume Vignaud,
  • Xavier Moppert,
  • Claire Hellio,
  • Fabienne Faÿ

DOI
https://doi.org/10.3390/md20110728
Journal volume & issue
Vol. 20, no. 11
p. 728

Abstract

Read online

Biofilms, responsible for many serious drawbacks in the medical and marine environment, can grow on abiotic and biotic surfaces. Commercial anti-biofilm solutions, based on the use of biocides, are available but their use increases the risk of antibiotic resistance and environmental pollution in marine industries. There is an urgent need to work on the development of ecofriendly solutions, formulated without biocidal agents, that rely on the anti-adhesive physico-chemical properties of their materials. In this context, exopolysaccharides (EPSs) are natural biopolymers with complex properties than may be used as anti-adhesive agents. This study is focused on the effect of the EPS MO245, a hyaluronic acid-like polysaccharide, on the growth, adhesion, biofilm maturation, and dispersion of two pathogenic model strains, Pseudomonas aeruginosa sp. PaO1 and Vibrio harveyi DSM19623. Our results demonstrated that MO245 may limit biofilm formation, with a biofilm inhibition between 20 and 50%, without any biocidal activity. Since EPSs have no significant impact on the bacterial motility and quorum sensing factors, our results indicate that physico-chemical interactions between the bacteria and the surfaces are modified due to the presence of an adsorbed EPS layer acting as a non-adsorbing layer.

Keywords